New China Life Insurance Company (HKG:1336) announced that the H share over-allotment option described in the prospectus was partially exercised by China International Capital Corporation Hong Kong Securities Limited, UBS AG, Hong Kong Branch and Goldman Sachs (Asia) L.L.C. on 6 January 2012 in respect of an aggregate of 2.587 million H shares, representing 0.72% of the offer shares initially available under the global offering, raising an additional HK$73.718 million.

New China Life said that the stabilization period in connection with the global offering ended on 6 January 2012. The stabilizing actions undertaken during the stabilization period were over-allocations of an aggregate of 53.763 million H shares in the international offering; successive market purchases which purchases were made at prices ranging from HK$22.95 to HK$26.55 per H share; and the partial exercise of the H Share over-allotment option in respect of 2.587 million additional H Shares solely to cover over-allocations in the international offering.